Sundrug CoSDGCF 75 Forward PE Ratio is 15.34 as of Jul. 12, 2026. GuruFocus rates SDGCF with a GF Score™ of 75/100 and a GF Value™ of $35.12. The stock has 1 warning sign investors should review. Among 314 Healthcare Providers & Services companies, Sundrug Co ranks better than 71.97% on this metric.
Sundrug Co (OTCPK:SDGCF) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Sundrug Co Forward PE Ratio Related Terms
Sundrug Co Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Sundrug Co's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sundrug Co Forward PE Ratio Chart
Sundrug Co Annual Data
Trend
2021-03
2022-03
2025-03
2026-03
Forward PE Ratio
17.01
13.76
15.25
14.72
Sundrug Co Quarterly Data
2021-03
2021-06
2021-09
2021-12
2022-03
2022-06
2022-09
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
17.01
15.53
16.08
13.40
13.76
14.64
17.54
15.65
15.25
14.53
14.86
14.49
14.72
Sundrug Co Forward PE Ratio Competitor Comparison
For the Pharmaceutical Retailers subindustry, Sundrug Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sundrug Co Forward PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sundrug Co's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Sundrug Co's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Sundrug Co (SDGCF) has a Forward PE Ratio of 15.34 as of Jul. 12, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Sundrug Co and its competitors. According to the industry distribution chart, Sundrug Co ranks #88 out of 314 companies in the Healthcare Providers & Services industry, placing it in the top 28%.
Is Sundrug Co's Forward PE Ratio too high?
Sundrug Co's current Forward PE Ratio is 15.34. The Healthcare Providers & Services industry median Forward PE Ratio is 18.20. Sundrug Co's value of 15.34 is 15.7% below this industry median. Based on the distribution chart, Sundrug Co ranks #88 out of 314 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Sundrug Co has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Sundrug Co's Forward PE Ratio compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Sundrug Co ranks #88 out of 314 companies for Forward PE Ratio. This puts Sundrug Co in the upper half of its industry. The industry median Forward PE Ratio is 18.20. Sundrug Co's value of 15.34 is 15.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Healthcare Providers & Services company?
The median Forward PE Ratio among Healthcare Providers & Services companies is 18.20, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sundrug Co's current Forward PE Ratio of 15.34 is 15.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Sundrug Co and its competitors. For the Healthcare Providers & Services industry, the median Forward PE Ratio is 18.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sundrug Co's current Forward PE Ratio is 15.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sundrug Co stock overvalued right now?
Sundrug Co (SDGCF) has a current Forward PE Ratio of 15.34. The stock's GF Value™ is $35.12, compared to a current price of $28.18 — trading 19.8% below its estimated fair value. The current Forward PE Ratio is 15.34 and 15.7% below the Healthcare Providers & Services industry median of 18.20. Sundrug Co's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Sundrug Co (SDGCF), the current Forward PE Ratio is 15.34 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sundrug Co (SDGCF) Overvalued in 2026?
Based on GuruFocus' analysis, Sundrug Co stock appears to be undervalued.
The current stock price of $28.18 is trading 19.8% below its estimated GF Value™ of $35.12.
Key valuation signals for SDGCF:
Forward PE Ratio: 15.34
GF Value™: $35.12 vs. price of $28.18 (19.8% below fair value)
Industry Position: 15.7% below the Healthcare Providers & Services median (#88 of 314)
No single metric tells the full story. See the SDGCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sundrug Co Ltd is a Japanese-based company engaged in the operation of drug stores and discount stores. The Group operates through two segments: the Drug Store Business, which mainly sells pharmaceuticals, cosmetics, and daily necessities, and the Discount Store Business, which mainly sells food products, household goods, and other related items. It generates the majority of its revenue from the Drugstore business segment.
75GF Score
Get the complete analysis for SDGCF
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SDGCF has been successfully added to your 